✦ LIBER ✦

Clinical pharmacological studies with the vasodilator endralazine in patients with renal impairment

✍ Scribed by H. L. Elliott; P. A. Meredith; L. Sloan; J. L. Reid

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical Pharmacology Basis of Deriving

✍ Hariharan, S.; Madabushi, R. 📂 Article 📅 2012 🏛 Sage Publications 🌐 English ⚖ 236 KB

Clinical pharmacokinetics of bezafibrate

✍ P. Anderson; H. -E. Norbeck 📂 Article 📅 1981 🏛 Springer 🌐 English ⚖ 538 KB

Clinical experience with nadroparin in p

✍ Wen ZHANG; Xiaonong CHEN; Yongxi CHEN; Nan CHEN 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB

safety of vildagliptin in patients with

✍ Francis, B.; Purkayastha, D.; Banerji, M.A. 📂 Article 📅 2009 🏛 Canadian Diabetes Association 🌐 English ⚖ 451 KB

Clinical and pharmacokinetic profiles of

✍ Allen, Nancy M.; Dunham, Gary; Sailstad, Jeff; Findlay, John 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 288 KB

Drug Development Perspective on Pharmaco

✍ Lalonde, R L; Wagner, J A 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 169 KB